Adherence to Antiretroviral Therapy in Turkey: Results from the ACTHIV-IST Study Group.
暂无分享,去创建一个
F. Tabak | M. Yemisen | A. Gunduz | I. Dokmetas | F. Sargın | N. Uzun | H. Kumbasar Karaosmanoğlu | Ozlem Altuntas Aydin | B. Mete | Dilek Yıldız Sevgi | F. Sargin
[1] F. Wabwire-mangen,et al. Reasons for Missing Antiretroviral Therapy: Results from a Multi-Country Study in Tanzania, Uganda, and Zambia , 2016, PloS one.
[2] A. Çağatay,et al. HIV-1 Transmitted Drug Resistance Mutations in Newly Diagnosed Antiretroviral-Naive Patients in Turkey. , 2016, AIDS research and human retroviruses.
[3] A. Gunduz,et al. Severe manifestation of psoriasis in a HIV infected patient: a case report - , 2015 .
[4] R. Ozaras,et al. Epidemiological profile of naive HIV-1/AIDS patients in Istanbul: the largest case series from Turkey. , 2014, Current HIV research.
[5] A. Westfall,et al. Medication Possession Ratio Predicts Antiretroviral Regimens Persistence in Peru , 2013, PloS one.
[6] V. Sychareun,et al. Adherence to Antiretroviral Therapy (ART) among People Living With HIV (PLHIV): a cross-sectional survey to measure in Lao PDR , 2013, BMC Public Health.
[7] B. Tran,et al. Determinants of antiretroviral treatment adherence among HIV/AIDS patients: a multisite study , 2013, Global health action.
[8] N. Terrin,et al. Medication Possession Ratio Associated with Short-Term Virologic Response in Individuals Initiating Antiretroviral Therapy in Namibia , 2013, PloS one.
[9] A. Gadkari,et al. The impact of specific HIV treatment-related adverse events on adherence to antiretroviral therapy: A systematic review and meta-analysis , 2012, AIDS care.
[10] P. Simkhada,et al. Factors Influencing Adherence to Antiretroviral Treatment in Nepal: A Mixed-Methods Study , 2012, PloS one.
[11] S. Lewin,et al. Pharmacy adherence measures to assess adherence to antiretroviral therapy: review of the literature and implications for treatment monitoring. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[12] Lizheng Shi,et al. Correlation between adherence rates measured by MEMS and self-reported questionnaires: a meta-analysis , 2010, Health and quality of life outcomes.
[13] L. Chen,et al. Suboptimal adherence to darunavir/ritonavir has minimal effect on efficacy compared with lopinavir/ritonavir in treatment-naive, HIV-infected patients: 96 week ARTEMIS data. , 2010, The Journal of antimicrobial chemotherapy.
[14] K. Peltzer,et al. Antiretroviral treatment adherence among HIV patients in KwaZulu-Natal, South Africa , 2010, BMC public health.
[15] A. Phillips,et al. Use of a prescription‐based measure of antiretroviral therapy adherence to predict viral rebound in HIV‐infected individuals with viral suppression , 2010, HIV medicine.
[16] B. Yip,et al. The Combined Effect of Modern Highly Active Antiretroviral Therapy Regimens and Adherence on Mortality Over Time , 2009, Journal of acquired immune deficiency syndromes.
[17] B. Chi,et al. Adherence to first-line antiretroviral therapy affects non-virologic outcomes among patients on treatment for more than 12 months in Lusaka, Zambia , 2009, International journal of epidemiology.
[18] R. Hogg,et al. Differential impact of adherence on long-term treatment response among naive HIV-infected individuals , 2008, AIDS.
[19] J. Miro,et al. Relationship between adherence level, type of the antiretroviral regimen, and plasma HIV type 1 RNA viral load: a prospective cohort study. , 2008, AIDS research and human retroviruses.
[20] B. Chi,et al. Simple adherence assessments to predict virologic failure among HIV-infected adults with discordant immunologic and clinical responses to antiretroviral therapy. , 2008, AIDS research and human retroviruses.
[21] H. Nagaraja,et al. Optimizing Measurement of Self-Reported Adherence With the ACTG Adherence Questionnaire: A Cross-Protocol Analysis , 2007, Journal of acquired immune deficiency syndromes.
[22] M. Chesney,et al. The Elusive Gold Standard: Future Perspectives for HIV Adherence Assessment and Intervention , 2006, Journal of acquired immune deficiency syndromes.
[23] I. Buchan,et al. Adherence to HAART : A Systematic Review of Developed and Developing Nation Patient-Reported Barriers and Facilitators , 2006 .
[24] Peter W. Dillingham,et al. Pharmacy-based assessment of adherence to HAART predicts virologic and immunologic treatment response and clinical progression to AIDS and death , 2004, International journal of STD & AIDS.
[25] J. Bartlett. Association between adherence to antiretroviral therapy and human immunodeficiency virus drug resistance , 2004 .
[26] A. Mocroft,et al. Decline in the AIDS and death rates in the EuroSIDA study: an observational study , 2003, The Lancet.
[27] A. Wu,et al. Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: The AACTG Adherence Instruments , 2000, AIDS care.